NL-OMON24829招募中不适用
IMPella versus IABP REduces mortality in STEMI patients treated with primary PCI IN SEVERE and deep cardiogenic SHOCK.<br>An international multicenter, randomized trial of the Impella* cVAD (left ventricular assist) device versus Intra Aortic Balloon Counter Pulsation (IABP) therapy for acute ST-elevation myocardial infarction patients treated with primary PCI in severe and deep cardiogenic shock.
Academic Medical Center, Departement of Cardiology0 个研究点目标入组 48 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 48
研究概览
简要总结
/A
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1. Delay between onset of chest pain and PCI ≤ 24-72 hours;
- •2. Cardiogenic shock defined as: systolic blood pressure ≤ 90 mmHg for > 30 minutes or the need for supportive measures to maintain a systolic blood pressure ≥ 90 mmHg;
排除标准
- •1. Severe aorta-iliac arterial disease impeding placement of either devices;
- •2. Known severe cardiac aortic valvular disease;
研究者
相似试验
已完成
不适用
IMPella versus IABP REduces mortality in STEMI patients treated with primary PCI IN SEVERE and deep cardiogenic SHOCK. An international multicenter, randomized trial of the Impella cVAD (left ventricular assist) device versus Intra Aortic Balloon Counter Pulsation (IABP) therapy for acute ST-elevation myocardial infarction patients treated with primary PCI in severe and deep cardiogenic shocksevere cardiogenic shockseverely depressed heart function1001108210011954NL-OMON39892Academisch Medisch Centrum43
暂停
不适用
IMPRESS in STEMI1. Acute ST-elevation myocardial infarction (Acuut ST-elevatie myocardinfarct)<br />2. cardiogenic pre-shock (cardiogene pre-shock).NL-OMON27760Dr.J.P.S.Henriques, MD, PhDAcademic Medical Center-University of Amsterdam, Department of Cardiology, room B2-116Meibergdreef 91105 AZAmsterdam, the Netherlandsemail:j.p.henriques@amc.uva.nlPhone +31205664585130
终止
不适用
MINI-AMI: Minimizing Infarct Size With Impella 2.5 Following PCI for Acute Myocardial InfarctionST-elevation Myocardial InfarctionNCT01319760Abiomed Inc.5
已完成
不适用
se of IABP to reduce mortality in extensive myocardial infarction with persistent ischemia.heart attack10028593myocardial infarctionNL-OMON42015Catharina-ziekenhuis100
终止
3 期
Protect II, A Prospective, Multicenter Randomized Controlled TrialCoronary Artery DiseaseNCT00562016Abiomed Inc.452